Radiation Oncology Market Report 2026

Radiation Oncology Market Overview

• Radiation Oncology market size has reached to $8.73 billion in 2025 • Expected to grow to $13.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Growing Cancer Cases Driving Demand For Advanced Treatment Due To Increasing Incidence And Early Detection • Market Trend: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiation Oncology Market?

Radiation oncology refers to a specialized area of medicine where high-energy radiation is used to treat cancer by damaging the deoxyribonucleic acid (DNA) of malignant cells, thereby preventing their growth and spread. This approach utilizes advanced methods to provide precise treatment, focusing on targeting the affected area while minimizing harm to surrounding healthy tissues. The main types of radiation oncology are external beam radiation therapy and internal beam radiation therapy. Internal beam radiation therapy, commonly known as brachytherapy, involves placing radioactive material directly into or near a tumor to deliver concentrated, localized radiation. It is used for various applications, including prostate cancer, breast cancer, lung cancer, head and neck cancer, colorectal cancer, cervical cancer, gynecological cancer, and others, catering to end users such as hospitals, cancer research institutes, and others.

What Is The Radiation Oncology Market Growth Forecast?

The radiation oncology market size is expected to see strong growth in the next few years. It will grow to $13.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing adoption of personalized oncology treatments, rising demand for stereotactic and proton therapies, expansion of AI-assisted treatment planning, growing focus on outpatient cancer care, increasing investments in advanced oncology equipment. Major trends in the forecast period include increasing adoption of image-guided radiation therapy, rising use of precision and targeted treatment techniques, growing integration of ai in treatment planning, expansion of advanced linear accelerator installations, enhanced focus on minimizing radiation exposure to healthy tissue.

Global Radiation Oncology Market Segmentation

1) By Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy 2) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Other Applications 3) By End-User: Hospitals, Cancer Research Institutes, Other End-Users Subsegments: 1) By Internal Beam Radiation Therapy: Brachytherapy, Endocavitary Brachytherapy, Interstitial Brachytherapy, Intraluminal Brachytherapy 2) By External Beam Radiation Therapy: 3D Conformal Radiation Therapy (3DCRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Image-Guided Radiation Therapy (IGRT)

What Is The Driver Of The Radiation Oncology Market?

The rising number of cancer cases worldwide is expected to significantly propel the growth of the radiation oncology market. Cancer incidence is increasing due to factors such as aging populations, lifestyle-related risk factors, and improved early detection. Cancer cases are rising due to the increasing exposure to risk factors such as unhealthy lifestyles and environmental pollutants, which contribute to higher mutation rates and the development of malignant cells over time. Radiation oncology uses high-energy radiation to destroy cancer cells, shrink tumors, and support surgical and chemotherapy interventions, with advanced techniques improving precision and outcomes. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, there were an estimated 20 million new cancer cases in 2022. The WHO/IARC also projects that by 2050, new cancer cases could rise to 35 million, a 77% increase over 2022 levels. Therefore, the increasing cancer burden is driving demand for advanced radiation oncology treatments.

Key Players In The Global Radiation Oncology Market

Major companies operating in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, ScandiDos.

Global Radiation Oncology Market Trends and Insights

Major companies operating in the radiation oncology market are focusing on developing advanced radiation therapy systems incorporating AI-powered imaging and adaptive technologies to enhance treatment precision, reduce side effects, and improve patient outcomes for diverse cancer treatment applications. AI-powered radiotherapy refers to the use of artificial intelligence technologies to enhance various aspects of radiation therapy, including treatment planning, imaging, delivery, and monitoring. For instance, in May 2024, Elekta, a Sweden-based medical technology company, launched Evo, its latest CT-Linac featuring high-definition AI-enhanced imaging designed to improve radiation therapy techniques. The versatile system supports offline and online adaptive radiation therapy along with enhanced standard image-guided radiation therapy, providing clinicians with greater precision and flexibility to tailor treatments for individual patients. This innovation aims to enhance patient outcomes by optimizing treatment accuracy and adaptability.

What Are Latest Mergers And Acquisitions In The Radiation Oncology Market?

In June 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Fusion Pharmaceuticals for an undisclosed amount. With this acquisition, AstraZeneca aims to strengthen its oncology portfolio by integrating Fusion’s innovative radioconjugate (RC) technology, particularly enhancing targeted cancer therapies such as FPI-2265 for metastatic castration-resistant prostate cancer (mCRPC), to advance precision oncology and reduce reliance on traditional treatments. Fusion Pharmaceuticals is a Canada-based clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

Regional Outlook

North America was the largest region in the radiation oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiation Oncology Market?

The radiation oncology market consists of revenues earned by entities by providing services such as tumor board consultations, radiation oncology equipment maintenance, telemedicine consultations, stereotactic radiosurgery (SRS), and image-guided radiation therapy (IGRT). The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology market also includes sales of radiation therapy equipment, treatment planning software, dosimetry systems, radiation protection products, and medical consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiation Oncology Market Report 2026?

The radiation oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.